Investigating the influence of the type of polymer on sustaining the supersaturation from amorphous solid dispersions of Apremilast and its pharmacokinetics
D Shetty, DL Yarlagadda, B Brahmam… - Journal of Drug Delivery …, 2023 - Elsevier
Apremilast, a BCS class IV drug, has minimal solubility in aqueous medium which results in
poor bioavailability. With an intention of enhancing the bioavailability, amorphous solid …
poor bioavailability. With an intention of enhancing the bioavailability, amorphous solid …
[PDF][PDF] 浅谈药物制剂制备技术助力我国药物制剂创新发展
王敬文， 王辉， 于锏茗， 刘骏炜… - 中国药学 …, 2023 - journal11.magtechjournal.com
药物制剂相关制备技术对药物制剂的发展起到了重要作用. 通过文献分析,
回顾近十年来制剂相关技术发展, 针对固体分散体制备技术, 热熔挤出技术 …
回顾近十年来制剂相关技术发展, 针对固体分散体制备技术, 热熔挤出技术 …
Research on Ternary Solid Dispersions of Celecoxib with Surfactant: Preparation, Characterization, and Solubility Property
T Li, X Fu, Y Wang, F Ouyang, L Liu, M Wen… - Russian Journal of …, 2024 - Springer
Celecoxib (CXB) is a nonsteroidal anti-inflammatory drug (NSAID). However, the application
of CXB has been compromised by its poor aqueous solubility and low oral bioavailability …
of CXB has been compromised by its poor aqueous solubility and low oral bioavailability …
石英纤维的表面改性及分散特性研究.
丁能鑫， 侯夫庆， 杨会康， 张春辉 - China Pulp & Paper, 2023 - search.ebscohost.com
本研究通过对石英纤维进行酸/碱溶液和表面活性剂结合的预处理方式, 改善其在水中的分散性,
重点研究了酸溶液, 碱溶液, 表面活性剂的种类及浓度对石英纤维分散特性的影响. 结果表明 …
重点研究了酸溶液, 碱溶液, 表面活性剂的种类及浓度对石英纤维分散特性的影响. 结果表明 …